Transaction · 0002009130-26-000006

Smith Nicholas Conrad

Smith Nicholas Conrad, PRES, reported a transaction classified as exercise at Alto Neuroscience, Inc. involving 55000.000000 shares for an estimated $127600.00. Reported holdings after the transaction were 79060.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MPRES
ANROAlto Neuroscience, Inc.
Filing timeOct 05
Trade dateOct 02, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$24.01
Pre-filing
1mo ago +52.6%1w ago +51.6%1d ago +51.6%
Returns since
7d30d90d180d1y

ANRO price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANRO since 2026-10-05Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0002009130-26-000006
Common Stock
Transaction date
Oct 02, 2026
Filed Oct 05, 2026, 08:59 PM · 3d delay
Shares
55.0k sh
$2.32 per share
Estimated value
$127k
Computed from shares × price
Holdings after
79.0k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
+6score
Filing-only score

+6

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT AND CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    25% of the shares underlying the option vested on September 8, 2022, and one forty-eighth (1/48th) of the shares underlying the option vested or shall vest in monthly installments thereafter, subject…

Original filing · 0002009130-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANRO